Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that accurate diagnosis is crucial for effectively treating common scalp disorders, which often have similar symptoms.

Metabolic syndrome and PCOS are related but separate conditions, with metabolic syndrome increasing the risk of heart disease and diabetes.

PPAR agonists show promise for skin conditions but need more research before being a main treatment.

Metformin combined with lifestyle changes improves insulin resistance and reduces testosterone levels in women with PCOS more than lifestyle changes alone.

People with polycystic ovary syndrome have a higher chance of having chronic thyroiditis.

The current methods for diagnosing polycystic ovary syndrome are too vague and may lead to misdiagnosis and problems in research.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

Celiac disease can cause skin problems that may get better with a gluten-free diet.

Acne severity is linked to higher levels of certain androgenic hormones, even when those levels are within the normal range.

Oral contraceptives help treat hyperandrogenic disorders, improving symptoms like excessive hair and acne.

Children's hair grows in different types from before birth through puberty, with growth rates and characteristics varying by age, sex, and race.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Lifestyle changes and weight loss are key for treating PCOS-related metabolic issues and infertility, with various medications available for specific symptoms.

DHT, a testosterone byproduct, causes male pattern baldness.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Excessive hair growth in women often has no known cause and is not linked to race or other hormonal symptoms.

The research found that anovulatory young women have higher androgen and hormone levels than those who ovulate, suggesting immature hormonal regulation rather than a specific condition.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

Low-dose finasteride effectively treats hirsutism, is safe, and cost-effective.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Working night shifts for four days can lower the body's ability to use insulin, which may increase the risk of type 2 diabetes.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Certain microRNAs in the fluid around eggs are linked to Polycystic Ovary Syndrome and may help diagnose it.